The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 20, 2020
Filed:
Jun. 29, 2017
Applicant:
Onyx Therapeutics, Inc., Thousand Oaks, CA (US);
Inventors:
Christopher J. Kirk, San Francisco, CA (US);
Susan D. Demo, San Francisco, CA (US);
Mark K. Bennett, Moraga Town, CA (US);
Assignee:
Onyx Therapeutics, Inc., Thousand Oaks, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/07 (2005.12); A61K 31/704 (2005.12); A61K 31/198 (2005.12); A61K 31/167 (2005.12); A61K 31/337 (2005.12); A61K 31/165 (2005.12); A61K 45/06 (2005.12); A61K 31/335 (2005.12); A61K 31/45 (2005.12); A61K 31/454 (2005.12); A61K 31/573 (2005.12);
U.S. Cl.
CPC ...
A61K 38/07 (2012.12); A61K 31/337 (2012.12); A61K 31/45 (2012.12); A61K 31/454 (2012.12); A61K 31/573 (2012.12); A61K 31/704 (2012.12);
Abstract
ABSTRACT The invention provides combination therapy, wherein one or more other therapeutic agents are administered agents are administered with peptide epoxyketones or a pharmaceutically acceptable salt thereof. Another aspect of the invention relates to treating cancer with a peptide epoxyketone administered in combination with another therapeutic agent.